Insider · CIK 0001846478
Ori Gutwerg
officer
Files at ANIP (ANI PHARMACEUTICALS INC). First filing Mar 7, 2025, latest Aug 14, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $884k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANIP: ANI PHARMACEUTICALS INC
ANIPOct 9, 2026 · close 73.89
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | ANI PHARMACEUTICALS INC | $508k 5,873 shares | -7% | +66% from low0% from high | |
| 37Weak | ANI PHARMACEUTICALS INC | $53k 881 shares | -1% | +12% from low-18% from high | |
| 29Weak | ANI PHARMACEUTICALS INC | $323k 5,384 shares | -5% | +12% from low-4% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -5,873 | $86.53 | $508k | 84,024 | Aug 14, 2025 |
| May 15, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -881 | $60.07 | $53k | 89,897 | May 16, 2025 |
| Mar 7, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -3,314 | $60.62 | $201k | 90,778 | Mar 14, 2025 |
| Mar 5, 2025 | ANIP ANI PHARMACEUTICALS INC | MOption exercise Common Stock | +300 | $31.49 | $9,447 | 99,476 | Mar 7, 2025 |
| Mar 5, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -300 | $60.03 | $18k | 99,176 | Mar 7, 2025 |
| Mar 5, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -5,084 | $60.00 | $305k | 94,092 | Mar 7, 2025 |
| Mar 5, 2025 | ANIP ANI PHARMACEUTICALS INC | MOption exercise Stock Option (right to buy)derivative | -300 | $31.49 | $9,447 | 13,204 | Mar 7, 2025 |
| Feb 28, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -1,570 | $61.89 | $97k | 99,176 | Mar 4, 2025 |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +15,668 | $0.00 | $0 | 92,895 | Feb 18, 2025 |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +10,444 | $0.00 | $0 | 103,339 | Feb 18, 2025 |
| Feb 14, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -1,426 | $58.92 | $84k | 101,913 | Feb 18, 2025 |
| Feb 15, 2025 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -1,167 | $58.92 | $69k | 100,746 | Feb 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.